These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
62 related items for PubMed ID: 21069729
1. Activating transcription factor 2 targets c-Fos, but not c-Jun, in growth plate chondrocytes. Li X, LuValle P. J Cell Biochem; 2011 Jan; 112(1):211-6. PubMed ID: 21069729 [Abstract] [Full Text] [Related]
2. Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes. Ma Q, Li X, Vale-Cruz D, Brown ML, Beier F, LuValle P. J Cell Biochem; 2007 May 15; 101(2):477-87. PubMed ID: 17219413 [Abstract] [Full Text] [Related]
3. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity. Chatton B, Bocco JL, Goetz J, Gaire M, Lutz Y, Kedinger C. Oncogene; 1994 Feb 15; 9(2):375-85. PubMed ID: 8290251 [Abstract] [Full Text] [Related]
4. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. De Cesare D, Vallone D, Caracciolo A, Sassone-Corsi P, Nerlov C, Verde P. Oncogene; 1995 Jul 20; 11(2):365-76. PubMed ID: 7624151 [Abstract] [Full Text] [Related]
5. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types. Barrett TJ, Vedeckis WV. Recept Signal Transduct; 1996 Jul 20; 6(3-4):179-93. PubMed ID: 9259052 [Abstract] [Full Text] [Related]
6. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors. Papassava P, Gorgoulis VG, Papaevangeliou D, Vlahopoulos S, van Dam H, Zoumpourlis V. Cancer Res; 2004 Dec 01; 64(23):8573-84. PubMed ID: 15574764 [Abstract] [Full Text] [Related]
7. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. Miller C, Zhang M, He Y, Zhao J, Pelletier JP, Martel-Pelletier J, Di Battista JA. J Cell Biochem; 1998 Jun 15; 69(4):392-413. PubMed ID: 9620167 [Abstract] [Full Text] [Related]
8. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription. James CG, Woods A, Underhill TM, Beier F. BMC Mol Biol; 2006 Sep 19; 7():30. PubMed ID: 16984628 [Abstract] [Full Text] [Related]
9. Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes. Beier F, Taylor AC, LuValle P. J Biol Chem; 2000 Apr 28; 275(17):12948-53. PubMed ID: 10777595 [Abstract] [Full Text] [Related]
10. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Echlin DR, Tae HJ, Mitin N, Taparowsky EJ. Oncogene; 2000 Mar 30; 19(14):1752-63. PubMed ID: 10777209 [Abstract] [Full Text] [Related]
14. Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Sabbah M, Courilleau D, Mester J, Redeuilh G. Proc Natl Acad Sci U S A; 1999 Sep 28; 96(20):11217-22. PubMed ID: 10500157 [Abstract] [Full Text] [Related]
16. Induction of early response genes in trypsin inhibitor-induced pancreatic growth. Guo L, Sans MD, Gurda GT, Lee SH, Ernst SA, Williams JA. Am J Physiol Gastrointest Liver Physiol; 2007 Feb 28; 292(2):G667-77. PubMed ID: 17095753 [Abstract] [Full Text] [Related]
17. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter. Hussain S, Kilbey A, Gillespie DA. Cell Growth Differ; 1998 Aug 28; 9(8):677-86. PubMed ID: 9716184 [Abstract] [Full Text] [Related]
18. Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells. Yukimasa N, Isobe K, Nagai H, Takuwa Y, Nakai T. Neuropeptides; 1999 Dec 28; 33(6):475-82. PubMed ID: 10657527 [Abstract] [Full Text] [Related]